Sotera Health (NASDAQ:SHC) Given Outperform Rating at Royal Bank of Canada

Royal Bank of Canada reaffirmed their outperform rating on shares of Sotera Health (NASDAQ:SHC) in a research report sent to investors on Thursday morning,Benzinga reports. The firm currently has a $17.00 target price on the stock.

A number of other analysts have also weighed in on SHC. Barclays increased their target price on shares of Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a report on Tuesday, August 6th. Citigroup increased their price target on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, November 6th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $16.50.

Sotera Health Stock Up 3.3 %

SHC stock opened at $12.82 on Thursday. The stock has a 50-day simple moving average of $15.61 and a two-hundred day simple moving average of $13.98. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.44. The firm has a market capitalization of $3.63 billion, a PE ratio of 51.28 and a beta of 2.08. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.01). The firm had revenue of $285.47 million during the quarter, compared to the consensus estimate of $278.64 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The firm’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.18 earnings per share. On average, equities analysts predict that Sotera Health will post 0.61 EPS for the current fiscal year.

Insider Buying and Selling at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the transaction, the director now directly owns 49,215,301 shares of the company’s stock, valued at $739,705,974.03. This trade represents a 16.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 55.12% of the company’s stock.

Institutional Trading of Sotera Health

Several hedge funds have recently modified their holdings of SHC. Wedmont Private Capital grew its stake in Sotera Health by 6.5% during the 3rd quarter. Wedmont Private Capital now owns 10,915 shares of the company’s stock valued at $169,000 after purchasing an additional 664 shares during the last quarter. First Citizens Bank & Trust Co. grew its holdings in shares of Sotera Health by 5.0% during the third quarter. First Citizens Bank & Trust Co. now owns 14,287 shares of the company’s stock worth $239,000 after buying an additional 677 shares in the last quarter. CWM LLC lifted its stake in Sotera Health by 86.1% in the 2nd quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after purchasing an additional 993 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of Sotera Health by 125.0% in the 3rd quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock worth $50,000 after acquiring an additional 1,660 shares during the last quarter. Finally, TD Asset Management Inc grew its stake in shares of Sotera Health by 1.5% in the 2nd quarter. TD Asset Management Inc now owns 123,454 shares of the company’s stock valued at $1,465,000 after buying an additional 1,800 shares during the period. 91.03% of the stock is owned by hedge funds and other institutional investors.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.